fda approved glp 1 pill Weight Loss Blog – Maryland Trim Clinic Hate needles? Wegovy's weight loss

drug databases

Circulation 117, 23402350

As global rates of obesity and cardiometabolic diseases soar, there is a growing need for novel solutions with demonstrated safety and effectiveness

Many researchers report their most dramatic visible changes during this period, even if the rate of scale weight loss slows slightly

Overall I like this deal for Pfizer and I imagine they will continue to invest heavily in building out the clinical programs for Metseras portfolio beyond obesity, both to help stem revenue loss from LOEs of ELIQUIS and eventually leverage that commercial footprint towards its budding obesity portfolio.